
Dolby Laboratories (DLB) Stock Forecast & Price Target
Dolby Laboratories (DLB) Analyst Ratings
Bulls say
Dolby Laboratories is supported by a dominant IP licensing model, enviable margins, and strong cash flow generation, which together create limited downside and a high-quality earnings profile. Its revenue outlook is reinforced by broad adoption of Atmos, Vision, and image patent licensing, with that segment expected to grow 15% to 20% over the next few years and about 30% penetration of Atmos and Vision on 4K TVs, while newer initiatives like VDP, OptiView, and automotive expand monetization beyond device shipments. Near-term fundamentals also look constructive, with consensus calling for $372.8M in revenue and $1.19 in non-GAAP EPS, while management guidance of $362M to $392M and a dividend of $1.44 annually with $150 million left on buybacks underscore shareholder returns.
Bears say
Dolby Laboratories is challenged by a business model that still depends heavily on convincing device makers to adopt newer offerings such as Atmos and Vision, because revenue growth and higher royalties per device are tied to that transition rather than to the more mature foundational audio base. Its licensing-led revenue stream also depends on accurately forecasting customer device shipments, making supply-chain disruptions and semiconductor shortages a direct risk to visibility, attach rates, and near-term growth. Governance is another concern: as of the end of September 2022, the Dolby family and affiliates controlled 84% of combined voting power through Class B shares, limiting outside shareholders’ influence over capital allocation and strategic change.
This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Dolby Laboratories (DLB) Forecast
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares